Novavax slips 4% after booster authorized by FDA



Novavax Inc. shares fell more than 4% during the trading session on Wednesday after the United States Food and Drug Administration (FDA) approved the company’s vaccine as a COVID-19 booster for ad…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento